The multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART): new methods for more potent eHealth interventions
Linda M Collins, Susan A Murphy, Victor Strecher, Linda M Collins, Susan A Murphy, Victor Strecher
Abstract
In this article two new methods for building and evaluating eHealth interventions are described. The first is the Multiphase Optimization Strategy (MOST). It consists of a screening phase, in which intervention components are efficiently identified for inclusion in an intervention or for rejection, based on their performance; a refining phase, in which the selected components are fine tuned and issues such as optimal levels of each component are investigated; and a confirming phase, in which the optimized intervention, consisting of the selected components delivered at optimal levels, is evaluated in a standard randomized controlled trial. The second is the Sequential Multiple Assignment Randomized Trial (SMART), which is an innovative research design especially suited for building time-varying adaptive interventions. A SMART trial can be used to identify the best tailoring variables and decision rules for an adaptive intervention empirically. Both the MOST and SMART approaches use randomized experimentation to enable valid inferences. When properly implemented, these approaches will lead to the development of more potent eHealth interventions.
Figures

Source: PubMed
Upcoming Clinical Trials
-
Inna Chen, MDHaukeland University Hospital; Azienda Ospedaliera di Padova; Hospital Universitario... and other collaboratorsNot yet recruitingPancreatic CancerDenmark, Italy, Norway, Romania, Spain
-
Guy's and St Thomas' NHS Foundation TrustKing's College London; Breathe Arts Health ResearchNot yet recruitingRehabilitation | Geriatric | Older Adults (65 Years and Older)United Kingdom
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Fondazione IRCCS Policlinico San Matteo di PaviaRecruitingHeredo Familial Tumors | Psycho Oncological SupportItaly
-
Hansoh BioMedical R&D CompanyNot yet recruitingPlatinum-sensitive Recurrent Ovarian CancerChina
-
Indiana UniversityMoi University; AudereNot yet recruitingAutism Spectrum DisorderUnited States, Kenya
-
Assiut UniversityNot yet recruitingPremature Birth | Bronchopulmonary Dysplasia | Respiration Failure
-
Assiut UniversityNot yet recruitingInflammatory Bowel Diseases | Crohn Disease | Pediatric Crohns Disease
-
Eisai Inc.RecruitingAlzheimer's DiseaseUnited States
-
Emory UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Not yet recruitingHuman Immunodeficiency VirusUnited States
-
AbbVieNot yet recruiting
-
Adraxe Corp.Not yet recruitingEpilepsy (Treatment Refractory)United States